Related Experiment Video
Updated: Jul 7, 2026
10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Hepatitis d.
Elif S Koytak1, Cihan Yurdaydin, Jeffrey S Glenn
1Jeffrey S. Glenn, MD, PhD Division of Gastroenterology and Hepatology, CCSR Building, Room 3115A, Stanford University School of Medicine, 269 Campus Drive, Palo Alto, CA 94305-5187, USA. jeffrey.glenn@stanford.edu.
Current Treatment Options in Gastroenterology
|January 29, 2008
Summary
Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) to replicate, causing severe liver disease. Chronic HDV infection often leads to cirrhosis, necessitating new treatments beyond interferon-alpha.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis delta virus (HDV) is an RNA virus dependent on hepatitis B virus (HBV) for replication and spread.
- HDV infection is globally distributed, with higher prevalence in tropical/subtropical regions.
- While HBV control has reduced HDV incidence in developed nations, it remains a persistent health concern.
Purpose of the Study:
- To summarize the epidemiology, clinical progression, and current therapeutic landscape of HDV infection.
- To highlight the urgent need for novel treatment strategies for chronic hepatitis D.
Main Methods:
- Literature review and synthesis of existing data on HDV epidemiology and clinical outcomes.
- Analysis of current treatment options, including interferon-alpha and liver transplantation.
- Identification of gaps in therapeutic approaches for HDV.
Main Results:
- Chronic hepatitis D progresses to cirrhosis in approximately 80% of cases within 5-10 years.
- Interferon-alpha is the sole approved therapy, with limited efficacy.
- Liver transplantation is an option for end-stage disease but does not prevent HDV recurrence.
Conclusions:
- HDV infection poses a significant global health challenge due to its rapid progression to cirrhosis.
- Current therapies for chronic hepatitis D are insufficient, underscoring the critical need for innovative treatment modalities.
- Further research into novel antiviral agents and therapeutic strategies is essential to combat HDV infection effectively.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...